About Suven Pharma
Suven Pharma is a company based in Hyderabad (India) founded in 1989 was acquired by Advent International in December 2022. It operates as a Professional Services. The company has 2,290 employees as of March 31, 2024. Suven Pharma has completed 3 acquisitions, including Casper Pharma, NJ Bio and Sapala Organics. Suven Pharma offers products and services including Formulation Development and Analytical Services, Process Research, Custom Synthesis, and Clinical Supplies Manufacturing & Packaging. Suven Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Hyderabad, India
- Employees 2290 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Cohance Lifesciences Ltd
-
Annual Revenue
$138.12 M (USD)13.94as on Mar 31, 2025
-
Net Profit
$31.37 M (USD)-10.79as on Mar 31, 2025
-
EBITDA
$46.7 M (USD)-1.34as on Mar 31, 2025
-
Latest Funding Round
Not available
- Investors
-
Employee Count
2290
as on Mar 31, 2024
-
Investments & Acquisitions
Casper Pharma
& 2 more
-
Acquired by
Advent International
(Dec 26, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Suven Pharma
Suven Pharma is a publicly listed company on the NSE with ticker symbol COHANCE in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Suven Pharma
Suven Pharma offers a comprehensive portfolio of products and services, including Formulation Development and Analytical Services, Process Research, Custom Synthesis, and Clinical Supplies Manufacturing & Packaging.
Services for formulation and analytical development are provided.
Efficient and cost-effective drug production is ensured here.
Novel molecules are accessed for cost-effective drug production.
Clinical trial supplies are delivered meeting regulatory requirements.
People of Suven Pharma
Unlock access to complete
Leadership Team
2 people
Human Resources and Administration
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Suven Pharma
Detailed funding history for Suven Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Suven Pharma
Suven Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advent International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Suven Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Suven Pharma
Suven Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Casper Pharma, NJ Bio and Sapala Organics.
Investment portfolio details for Suven Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical development services are provided for biotechnology applications.
|
Locked | Locked | 2018 | Locked | |
|
Specialty pharmaceuticals in key therapeutic areas are developed and commercialized.
|
Locked | Locked | 2016 | Locked | |
|
Research organization specializing in custom synthesis of various organic compounds
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Suven Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Suven Pharma
Detailed financials for Suven Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Suven Pharma Comparisons
Peer comparison for Suven Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Suven Pharma
Suven Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Suven Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Suven Pharma
Complete news archive for Suven Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suven Pharma
Suven Pharma was founded in 1989.
Suven Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Venkateswarlu Jasti is the current CEO of Suven Pharma.
As of Mar 31, 2024, the latest employee count at Suven Pharma is 2,290.
Annual revenue of Suven Pharma is $138.12M as on Mar 31, 2025.
Suven Pharma is involved in providing contract development and manufacturing services for global pharmaceutical companies. The company focuses on formulation development, analytical services, process research, custom synthesis, and clinical supplies manufacturing. Operations are centered around supporting healthcare customers from lab to commercialization, with an emphasis on new chemical entities and fine chemical intermediates. Facilities and expertise are utilized to ensure efficient, safe, and cost-effective production across various pharmaceutical segments.
Suven Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Suven Pharma offers Formulation Development and Analytical Services, Process Research, Custom Synthesis, and Clinical Supplies Manufacturing & Packaging.
Yes, Suven Pharma is publicly traded on NSE under the ticker symbol COHANCE.
Suven Pharma has made 3 acquisitions, including Casper Pharma, NJ Bio, and Sapala Organics.
Suven Pharma has 1 investor. Key investors include Advent International.
The ticker symbol of Suven Pharma is COHANCE on NSE.